|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/343 | |
| A61K 31/506 | |||
| A61K 31/661 | |||
| A61K 31/675 | |||
| A61K 31/69 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2854796 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13797528.0 |
| Date of filing the European patent application | 2013-06-03 | |
| (97) | Date of publication of the European application | 2015-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2013/000581 |
| Date | 2013-06-03 |
| (87) | Number | WO 2013/177633 |
| Date | 2013-12-05 |
| (30) | Number | Date | Country code |
| 2012902291 | 2012-06-01 | AU |
| (72) |
INGLIS, Daniel, J., AU
LAVRANOS, Tina, C., AU
KREMMIDIOTIS , Gabriel, AU
|
| (73) |
Bionomics Limited,
31 Dalgleish Street, Thebarton, South Australia 5031,
AU
|
| (54) | COMBINATIONS OF A VASCULAR DISRUPTING AGENT AND A HYPOXIA-TARGETING AGENT FOR USE IN THE TREATMENT OF CANCER |
| COMBINATIONS OF A VASCULAR DISRUPTING AGENT AND A HYPOXIA-TARGETING AGENT FOR USE IN THE TREATMENT OF CANCER |